Lehman C D, White E, Peacock S, Drucker M J, Urban N
Department of Radiology, University of Washington Medical Center, Seattle 98195-7115, USA.
AJR Am J Roentgenol. 1999 Dec;173(6):1651-5. doi: 10.2214/ajr.173.6.10584815.
The objective of this study was to examine the effect of breast density and age on screening mammograms with false-positive findings.
The study sample was taken from the Washington State Mammography Tumor Registry, which links data from participating radiologists with the Puget Sound Cancer Surveillance System and the Washington State Cancer Registry. Participants (n = 73,247) were women 35 years old and older who underwent screening mammography for which an assessment and a four-category density rating were coded. A total of 46,340 mammograms were sampled to avoid interpreter bias. In this study of false-positive mammograms, only women with no diagnosis of breast cancer within 12 months of the index mammogram were included. Logistic regression was used to estimate the odds ratios of a false-positive mammogram being associated with each category of breast density or age, adjusting for the other factor as a covariate.
After controlling for breast density, we found that the risk of a false-positive mammogram was not affected by age (p = 27). However, the trend of increasing risk of a false-positive mammogram with increasing breast density was highly significant (p < .001). Women with extremely dense breast tissue were almost two times more likely to have a false-positive mammogram than were women with fatty breast tissue. This effect persisted after controlling for age.
Breast density, not age, is an important factor when predicting risk of a false-positive mammogram. Breast density should be considered when educating individual women on the risks and benefits of screening mammography.
本研究的目的是探讨乳腺密度和年龄对有假阳性结果的乳腺钼靶筛查的影响。
研究样本取自华盛顿州乳腺钼靶肿瘤登记处,该登记处将参与的放射科医生的数据与普吉特海湾癌症监测系统和华盛顿州癌症登记处的数据相链接。参与者(n = 73247)为35岁及以上接受乳腺钼靶筛查的女性,筛查结果有评估且有四类密度评级编码。共抽取46340份乳腺钼靶影像以避免解读偏倚。在这项关于乳腺钼靶假阳性的研究中,仅纳入在索引乳腺钼靶检查后12个月内未诊断出乳腺癌的女性。采用逻辑回归来估计乳腺钼靶假阳性与每类乳腺密度或年龄相关的比值比,并将另一个因素作为协变量进行校正。
在控制乳腺密度后,我们发现乳腺钼靶假阳性的风险不受年龄影响(p = 0.27)。然而,乳腺钼靶假阳性风险随乳腺密度增加而增加的趋势非常显著(p < 0.001)。乳腺组织极度致密的女性出现乳腺钼靶假阳性的可能性几乎是乳腺组织为脂肪型的女性的两倍。在控制年龄后,这种效应仍然存在。
预测乳腺钼靶假阳性风险时,重要因素是乳腺密度而非年龄。在向个体女性讲解乳腺钼靶筛查的风险和益处时,应考虑乳腺密度。